Tradestie Institutional Equity Comparison Engine

VCYT vs ADPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCYT Overall Edge

VCYT Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Veracyte, Inc. (VCYT) driven by superior Valuation, Growth & Margin while ADPT counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VCYT trades at 15.3x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus ADPT at N/M Forward P/E and -16.2% operating margin (-10.7% YoY). In options structure, VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against ADPT sits in CONSOLIDATION (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
VCYT 15.3x vs ADPT N/M Fwd P/E
Growth & Margin Winner VCYT
Op Margin 15.0% vs -16.2% ยท YoY +15.1% vs -10.7%
Momentum & Technical Winner ADPT
1Y -39.8% vs +97.1% ยท 52W Pos 5% vs 78%
Options & Structure Winner ADPT
BREAKDOWN (47th %ile IV) vs CONSOLIDATION (36th %ile IV)
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0
ADPT NASDAQ
Adaptive Biotechnologies Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$27.87
-4.03% 1D
Market Cap $4.7B
1M Return +16.03%
1Y Return +97.1%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 43.0 Flow 69.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VCYT -39.78% ADPT +97.1% Spread: +136.88 pp (ADPT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VCYT Revenue ADPT Revenue VCYT Op. Margin ADPT Op. Margin Margin Edge
FY2018 $90M $60M -24.2% -89.4% VCYT
FY2019 $120M $90M -12.6% -92.1% VCYT
FY2020 $120M $100M -30.1% -155.3% VCYT
FY2021 $220M $150M -37.3% -135.4% VCYT
FY2022 $300M $190M -13.9% -108.0% VCYT
FY2023 $360M $170M -23.8% -133.3% VCYT
FY2024 $450M $180M 3.6% -90.8% VCYT
FY2025 $520M $280M 11.2% -20.6% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VCYT (7) vs ADPT (3)
Institutional Metric VCYT ADPT Criterion Row Winner
Market Capitalization Scale $2.0B $4.7B Larger Scale ADPT
Trailing P/E Ratio Valuation 15.8x N/M Lower Multiple VCYT
Forward P/E Ratio Valuation 15.3x N/M Lower Multiple VCYT
Revenue Growth (YoY) Growth +15.1% -10.7% Higher Growth VCYT
Operating Margin (TTM) Profitability 15.0% -16.2% Higher Margin VCYT
Net Profit Margin Profitability 21.8% -23.7% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency 9.4% -36.4% Higher ROE VCYT
52-Week Range Position Momentum 5% ($22โ€“$61) 78% ($12โ€“$32) Stronger Trend ADPT
Beta / 30D Volatility Risk Regime 3.01ฮฒ ยท 199% Vol 1.74ฮฒ ยท 60% Vol Lower Realized Risk ADPT
Unified Institutional Score Composite Signal 49.1 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VCYT vs ADPT Buy Guide
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ADPT CONSOLIDATION
69d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ADPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VCYT nor ADPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.